Amol Ghadge

• Currently leading the marketing team of Hospitals BU working with 7 CBMs to drive marketing transformation across portfolio of AIs including Zavicefta, Merrem, Sulperazone, Antifungal Portfolio (Cresemba, Eraxis) valued at $75M
• Led the BM 3.3 transformation to drive Omnichannel Engagements across portfolio with innovative and breakthrough assets across brand portfolios
• Eg MLPs, #KNOWAMR, Lead Gen Campaigns, Social Media (Fb & Insta), PfizerAMS (You tube channel)
• Zavicefta 360 degree marketing post LOE through physical & digital channels such as Whatsapp (leaders in Pfizer India with 5000+ HCPs onboarded), Lead Gen Campaigns, KOL testimonial Series, Value Programs with key scientific partnerships (BMJ, TNAI, IPA) which has helped drive 48% growth with the EI of 108 (YTD June’23 IQVIA)
• Innovative Contracting Model with Geo Pricing Implementation; customized account journey mapping with analytical dashboards for performance monitoring
• Led the Diagnostic Stewardship initiatives with 300+ accounts supported, building innovation through Rapid diagnostics tools (cost effective)
• Won the EM Asia Bug Tank funding for innovative idea ($100000)
• Prior to HBU, Lead the marketing team of Women’s Health & Respiratory portfolio of Internal Medicine category to build sustainable marketing strategies for the portfolio of Oral Contraceptives, Maternal Nutrition and Menopause in Indian Market
• Spearheaded the Digital transformation in Marketing utilizing Social Media, Influencer Marketing, Digital Channels & Consumer Platforms for building virtual consumer journeys in Oral Contraception, Preconception and enhance Healthcare Professionals’ & Consumer experiences with Pfizer products
• Spillthebeans became successful digital campaign with significant recognitions at India Leadership
• Drove Marketing Transformation through digital asset build up, technology integration & stakeholder collaborations to build Digital Promotion ecosystem as part of Go To Market Transformation
• Lead Strategy & Business expansion projects such as Govt Hospital expansion, Distributor Engagement Programs to tap current & future market opportunities, create blueprints and drive seamless execution in a multifunctional stakeholder network

• Building Brand Portfolio of INR 200+ Cr of CNS therapy for Abbott by strong establishment of the current portfolio and by strategic launches/In licensing of molecules to move towards category leadership
• Developing innovative marketing solutions with a mix of Digital, PR & Outreach programs to engage stakeholders in order to increase market share and expand reach
• Drive Portfolio in diverse therapies such as Epilepsy, Depression, Bipolar Disorder & Stroke to deliver profitable growth by building strong equity at HCPs
• Leading a team of three marketers to drive the brands and create meaningful scientific solutions for key stakeholders – HCPs and Patients
• Awarded with Abbott Excellence awards consecutively 3 years for exceptional marketing initiatives

• Driving the Marketing of key brands of Neurology Portfolio – EPILEX (Sodium Valproate) and LEVILEX (Levetiracetam)
• Total Portfolio Size is of INR 40 Crores
• Key Achievements:
• Received three awards – VP Award, Annual Gold award of performance, ACE Gallantry Award for extra ordinary performance of the portfolio
• Arrested the degrowth of EPILEX at Internal & External Performance markers with the help of aggressive and sustainable marketing initiatives
• Drove the engagement of Neurologists through Scientific Initiatives such as NEUROSPHERE, EPILEPSY Focus Group Discussion
• Creative In-Clinic Marketing Campaigns to drive the performance of all SKUs of EPILEX & LEVILEX
• Fostered Field Force engagement through competitive campaigns to drive brand growth
• Digital Initiatives – Webinar Series with Cleveland Clinics, White Board Case Series, Emailers with Epilepsy Updates at Pediatric Neurologists

• Established Epilepsy Franchise with research brand – LAMICTAL(Lamotrigine) & ICTACETAM (Levetiracetam- branded generics) with effective marketing strategies and KOL engagement
• Built LAMICTAL to be fastest growing brand in Lamotrigine category (growth of 55% YOY) with the help of innovative scientific engagements with Neurologists & Psychiatrists
• Successful International Speaker Tours (4 ISPs) to shape the Prescribing Behaviour of Customers
• Digital Engagements – Introduced & Implemented digital engagement platforms for customers such as Video Conferencing, Live Webinars to drive the therapy discussions amongst Neurologists & Psychiatrists
• Successful liasoning with International Epilepsy bodies to upgrade the knowledge of Indian Neurologists

· Worked as Product Manager in Acute Care Division of Abbott, handling a diverse portfolio of 42 Crores.

· Handled brands of Cefpodoxime and Combinations, other large golden brands such as Bactrim(Sulfamethoxazone+TrimethoprimCombination),Ascabiol(Cetrimide), Aquaviron(Testosterone Injectables) etc. with an exposure to Paediatricians, Consulting Physicians, ENT & General Physicians

· Was responsible for top & Bottom Line target achievement of a diverse portfolio with innovative Marketing Campaigns and Result Oriented investment model to achieve the organizational goals

· Worked as a Product Manager in Neuropsychiatry Division (Mindvision) of Lupin, handling a diverse portfolio of 20 Crores in the areas of Stroke, Neuropathic Pain & Insomnia.

· New product launch: TRANSDOL (Novel centrally acting analgesic-Tapentadol)

· Brand extension launch: CITISTAR PM